Research & Development
US Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Programme with Three New Phase 3 Trials
15 February 2019 - - US-based biopharmaceutical company Merck (NYSE: MRK) has presented interim data from the Phase 1b/2 KEYNOTE-365 umbrella trial investigating Keytruda, Merck's anti-PD-1 thera...
Affinivax Initiates Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collaboration with Astellas
15 February 2019 - - The first subject has been dosed with ASP3772, US-based Affinivax, Inc.'s novel MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus), the company said.
Leiters partners with Mobius Therapeutics for marketing of Mitosol
15 February 2019 - Medication company Leiters disclosed on Thursday the launch of a national sales and marketing agreement for the ophthalmic product Mitosol from Mobius Therapeutics.Mobius Therapeuti...
SIG Medical awarded US FDA's clearance for next gen AdvantageRib System
15 February 2019 - Healthcare system company SIG Medical reported on Thursday the receipt of the US Food and Drug Administration's (FDA) 510(k) clearance for its enhanced AdvantageRib System, K18...
Tanabe Research Laboratories USA Inc files first IND application with the US FDA for phase I trial of TR1801-ADC in cMet positive solid tumours patients
15 February 2019 - Tanabe Research Laboratories USA Inc (TRL) revealed on Thursday that it has successfully submitted its first Investigational New Drug (IND) application with the US Food and Drug adm...
The US FDA authorises marketing of first interoperable insulin pump to allow patients to customise treatment through individual diabetes devices
15 February 2019 - Public health agency The U.S. Food and Drug Administration Thursday granted approval of the marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technolog...